Management of bacterial infections in cirrhosis
References (126)
- et al.
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis
Hepatology
(2002) - et al.
Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey
Chest
(2003) - et al.
Patients with acute on chronic liver display “sepsis-like” immune paralysis
J Hepatol
(2005) - et al.
Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients
Gastroenterology
(1993) - et al.
Sepsis: a new hypothesis for pathogenesis of the disease process
Chest
(1997) - et al.
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club
J Hepatol
(2000) - et al.
Diurnal variation and dispersion in QT interval in cirrhosis: relation to haemodynamic changes
J Hepatol
(2007) - et al.
The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome
J Hepatol
(2009) - et al.
Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis
Diagn Microbiol Infect Dis
(2005) - et al.
Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver
J Lab Clin Med
(2005)
Procalcitonin is the best diagnostic and prognostic marker of sepsis in decompensated cirrhotic patients
J Hepatol
(2010)
Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips
Hepatology
(2003)
Ascitic fluid lactoferrin for diagnosis of spontaneous bacterial peritonitis
Gastroenterology
(2008)
Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management
J Hepatol
(2010)
Current efficacy of recommended empirical antibiotic therapy in patients with cirrhosis and bacterial infection
J Hepatol
(2009)
Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage
Gastroenterology
(1982)
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
J Hepatol
(2000)
Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study
J Hepatol
(2000)
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis
Gastroenterology
(1996)
Cardiovascular, renal and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis
Hepatology
(2003)
Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis
J Hepatol
(2004)
Effects of albumin administration in patients with cirrhosis and bacterial infections other than SBP. A randomized controlled study
J Hepatol
(2009)
Bacterial infection in the pathogenesis of variceal bleeding
Lancet
(1999)
Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal haemorrhage
Gastroenterology
(1992)
Systemic antibiotic prophylaxis after gastrointestinal haemorrhage in cirrhotic patients with a high risk of infection
Hepatology
(1996)
The effect of ciprofloxacin in the prevention of bacterial infections in patients with cirrhosis after upper gastrointestinal bleeding
Am J Gastroenterol
(1998)
Cirrhotic patients are at risk for health care-associated bacterial infections
Clin Gastroenterol Hepatol
(2010)
Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis
Hepatology
(1999)
Bacterial infection in cirrhosis, with and without hepatocellular carcinoma
Am J Gastroenterol
(1993)
Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration
Hepatology
(1992)
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial
Hepatology
(1990)
Severe sepsis in cirrhosis
Hepatology
(2009)
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis
Gastroenterology
(2010)
Coagulation disorders in patients with cirrhosis and severe sepsis
Liver Int
(2003)
Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome
Hepatology
(2007)
Bacterial translocation (BT) in cirrhosis
Hepatology
(2005)
Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis
Hepatology
(2010)
Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis
J Hepatol
(2010)
Toll-like receptor (TLR) 2 promotor and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis
J Hepatol
(2011)
Excessive in vitro bacterial lipolysaccharide-induced production of monkines in cirrhosis
Hepatology
(1990)
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality
Hepatology
(1998)
Evidence of neutrophil functional defect despite inflammation in stable cirrhosis
J Hepatol
(2011)
Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis
Liver Int
(2009)
Bacterial infections, sepsis, and multiorgan failure in cirrhosis
Semin Liver Dis
(2008)
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
Crit Care Med
(1992)
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure
Hepatology
(2007)
Inflammation markers in point-of-care testing (POCT)
Anal Bioanal Chem
(2009)
Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis
J Clin Endocrinol Metab
(2001)
Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department
Acad Emerg Med
(2011)
C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction
Intensive Care Med
(2006)
Cited by (283)
Bacterial infections in cirrhosis: Challenges and perspectives
2022, Acta Colombiana de Cuidado IntensivoVaccination in Chronic Liver Disease: An Update
2022, Journal of Clinical and Experimental HepatologyRelationship Between Etiology of Cirrhosis and Survival Among Patients Hospitalized in Intensive Care Units
2022, Mayo Clinic ProceedingsPeripheral vasculature in portal hypertension
2022, Cardio-Hepatology: Connections Between Hepatic and Cardiovascular Disease
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. All rights reserved.